logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Mikio Sugimoto

Faculty of Medicine

25H-index
275Paper Count
3.4KCitation Count
Published Papers 50
Publication Date
logo
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel
errInternational Journal of Clinical Oncology
IF2.8
err2026-03-25
err0
PREAI
errTakuma Kato; Yoichiro Tohi; Atsushi Takamoto; Ryutaro Shimizu; Kei Daizumoto; Satoshi Katayama; Keita Kobayashi; Hirofumi Morinaka; Kenichi Nishimura; Hideo Fukuhara; Shuichi Morizane; Junya Furukawa; Motoo Araki; Koji Shiraishi; Yoshiyuki Miyaji; Noriyoshi Miura; Keiji Inoue; Mikio Sugimoto
errShare
errSave
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study
errBJU International
IF4.4
err2026-01-29
err0
PREAI
errTakuma Kato; Akira Yokomizo; Ryuji Matsumoto; Hiroshi Fukuhara; Yoichiro Tohi; Keiichiro Mori; Masaki Shiota; Toru Kanno; Yoichi Fujii; Shinichi Sakamoto; Kazuhiro Suzuki; Yasuo Kojimoto; Masashi Nakayama; Takayuki Goto; Yoh Matsuoka; Katsuyoshi Hashine; Yukio Naya; Yasuyuki Sakai; Takuma Sato; Mikio Sugimoto
errShare
errSave
Successful Robot-Assisted Resection of a Retroperitoneal Cystic Tumor With Fluorescent Ureteral Stent and Firefly Imaging
errIJU Case Reports
IF0.6
err2025-12-12
err0
errOAAI
errTohi, Yoichiro; Kohashiguchi, Kana; Tanaka, Kenichi; Jinno, Mari; Kato, Takuma; Taoka, Rikiya; Ueda, Nobufumi; Haba, Reiji; Nishiyama, Yoshihiro; Sugimoto, Mikio
errShare
errSave
Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial
errINTERNATIONAL JOURNAL OF UROLOGY
IF2.2
err2025-12-01
err1
PREAI
errTaoka, Rikiya; Fukuhara, Hideo; Miyake, Makito; Kobayashi, Keita; Ikeda, Atsushi; Kanao, Kent; Komai, Yoshinobu; Fujiwara, Ryo; Sato, Yusuke; Sugimoto, Mikio; Tsuzuki, Toyonori; Fujimoto, Kiyohide; Inoue, Keiji; Oya, Mototsugu
errShare
errSave
A Case of Prostatic Abscess Secondary to Postoperative Wound Infection Caused by Mycobacterium mageritense
errINTERNAL MEDICINE
IF1.1
err2025-12-01
err0
PREAI
errFukumori, Yusuke; Nishimura, Keiko; Tohi, Yoichiro; Osaki, Yu; Sugimoto, Mikio; Aono, Akio; Mitarai, Satoshi; Kamada, Keisuke; Yokota, Kyoko
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-κB and STAT3 pathways highlighting mechanisms of immune evasion and potential for combination therapy
errBMC Immunology
IF2.7
err2025-10-03
err0
errOAAI
errHirohito Naito; Rikiya Taoka; Xia Zhang; Akram Hossain; Yohei Abe; Mikio Sugimoto
errShare
errSave
Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study)
errJAPANESE JOURNAL OF CLINICAL ONCOLOGY
IF2.2
err2025-10-01
err0
PREAI
errTerada, Naoki; Nihei, Keiji; Aizawa, Rihito; Narita, Shintaro; Kojima, Takahiro; Shiota, Masaki; Akamatsu, Shusuke; Kimura, Takahiro; Inoue, Takahiro; Sugimoto, Mikio; Sekino, Yuta; Sasaki, Keita; Shibata, Taro; Fukuda, Haruhiko; Nishiyama, Hiroyuki; Kitamura, Hiroshi; Mizowaki, Takashi; Kamot, Toshiyuki
errShare
errSave
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation
errTARGETED ONCOLOGY
IF4
err2025-05-21
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Neal Shore; Daniel J. George; Mototsugu Oya; Mikio Sugimoto; Rana R. McKay; Maha Hussain; Noel W. Clarke
errShare
errSave
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment
errBJU INTERNATIONAL
IF4.4
err2025-04-01
err0
errOAAI
errde Vos, Ivo I.; Marenghi, Cristina; Badenchini, Fabio; Boeve, Egbert R.; Lozano-Urunuela, Francisco; Graefen, Markus; Rannikko, Antti S.; Staerman, Frederic; Sugimoto, Mikio; Kato, Takuma; Somford, Diederik M.; Frydenberg, Mark; Bangma, Chris H.; Remmers, Sebastiaan; Roobol, Monique J.
errShare
errSave
Efficacy of photodynamic diagnosis for non-muscle invasive bladder cancer: Exploratory subject-based analysis in a prospective, single-arm, multicenter phase III trial
errPHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
IF2.6
err2025-03-01
err0
errOAAI
errTaoka, Rikiya; Fukuhara, Hideo; Miyake, Makito; Kobayashi, Keita; Ikeda, Atsushi; Kanao, Kent; Komai, Yoshinobu; Fujiwara, Ryo; Sato, Yusuke; Sugimoto, Mikio; Tsuzuki, Toyonori; Fujimoto, Kiyohide; Inoue, Keiji; Oya, Mototsugu
errShare
errSave
Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment
errinternational journal of oncology
IF2.8
err2025-02-14
err0
errOAAI
errOhba, Kojiro; Osawa, Takahiro; Kojima, Takahiro; Hara, Tomohiko; Sugimoto, Mikio; Eto, Masatoshi; Minami, Keita; Nakai, Yasutomo; Ueda, Kosuke; Naito, Sei; Nonomura, Norio; Murai, Sachiyo; Nishiyama, Hiroyuki; Nakanishi, Hiromi; Mukae, Yuta; Mitsunari, Kensuke; Matsuo, Tomohiro; Imamura, Ryoichi; Shinohara, Nobuo
errShare
errSave
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
errEuropean Urology Oncology
IF9.3
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
errShare
errSave
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry
errEuropean Urology Oncology
IF9.3
err2024-07-01
err0
errOAAI
errChris Bangma; Paul Doan; Lin Zhu; Sebastiaan Remmers; Daan Nieboer; Jozien Helleman; Monique J. Roobol; Mikio Sugimoto; Byung Ha Chung; Lui Shiong Lee; Mark Frydenberg; Laurence Klotz; Michael Peacock; Antoinette Perry; Anders Bjartell; Antti Rannikko; Mieke Van Hemelrijck; Prokar Dasgupta; Caroline Moore; Bruce J. Trock; Christian Pavlovich; Ewout Steyerberg; Peter Carroll; Kyo Chul Koo; Andrew Hayen; James Thompson
errShare
errSave
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)
errBJU INTERNATIONAL
IF4.4
err2024-06-17
err3
PREAI
errKato, Takuma; Matsumoto, Ryuji; Yokomizo, Akira; Tohi, Yoichiro; Fukuhara, Hiroshi; Fujii, Yoichi; Mori, Keiichiro; Sato, Takuma; Inokuchi, Junichi; Hashine, Katsuyoshi; Sakamoto, Shinichi; Kinoshita, Hidefumi; Inoue, Koji; Tanikawa, Toshiki; Utsumi, Takanobu; Goto, Takayuki; Hara, Isao; Okuno, Hiroshi; Kakehi, Yoshiyuki; Sugimoto, Mikio
errShare
errSave
Efficacy of olaparib (ola) plus abiraterone (abi) vs placebo (pbo) plus abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err1
errOAAI
errMehra, N.; Clarke, N. W.; Armstrong, A. J.; Oya, M.; Shore, N. D.; Procopio, G.; Guedes, J. D. C.; Arslan, C.; Parnis, F.; Brown, E.; Schlurmann, F.; Joung, J. Y.; Sugimoto, M.; Choi, Y. D.; Castellano, D.; Urun, Y.; Hosius, C.; Desai, C.; Degboe, A.; Saad, F.
errShare
errSave
Oral 5-aminolevulinic acid administration before transurethral resection of bladder tumor induces perioperative nausea and vomiting
errPHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
IF2.6
err2023-09-01
err3
errOAAI
errTaoka, Rikiya; Yamada, Keisuke; Sawanobori, Yoshiharu; Honda, Tomoko; Osaki, Yu; Abe, Yohei; Naito, Hirohito; Tohi, Yoichiro; Matsuoka, Yuki; Kato, Takuma; Okazoe, Homare; Ueda, Nobufumi; Sugimoto, Mikio
errShare
errSave
Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries
errEUROPEAN UROLOGY
IF25.2
err2023-08-01
err3
PREAI
errMakaroff, Lydia E.; Filicevas, Alex; Boldon, Shannon; Hensley, Patrick; Black, Peter C.; Chisolm, Stephanie; Demkiw, Stephanie; Fernandez, Mario I.; Sugimoto, Mikio; Jensen, Bente Thoft; Witjes, Wim P. J.; Bagshaw, Ken; Cirefice-Funk, Lori; Knight, Allen; Kamat, Ashish M.
errShare
errSave
Simple Identification of Diverting Ureters With Ileal Conduit Using Fluorescent Ureteral Catheter During Laparoscopic Rectal Cancer Surgery
errDISEASES OF THE COLON & RECTUM
IF3.7
err2023-01-06
err2
PREAI
errKondo, Akihiro; Kumamoto, Kensuke; Asano, Eisuke; Tsunemori, Hiroyuki; Sugimoto, Mikio; Okano, Keiichi
errShare
errSave
Quantitative [99mTc]Tc-MDP SPECT/CT correlated with [18F]NaF PET/CT for bone metastases in patients with prostate cancer
errEJNMMI PHYSICS
IF3.2
err2022-12-05
err3
errOAAI
errTanaka, Kenichi; Norikane, Takashi; Mitamura, Katsuya; Yamamoto, Yuka; Maeda, Yukito; Fujimoto, Kengo; Takami, Yasukage; Ishimura, Mariko; Arai-Okuda, Hanae; Tohi, Yoichiro; Kudomi, Nobuyuki; Sugimoto, Mikio; Nishiyama, Yoshihiro
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Ewout W. Steyerberg
H-index: 176 · Papers: 1.9K
P
Peter R. Carroll
H-index: 149 · Papers: 1.4K
F
Fred Saad
H-index: 127 · Papers: 1.9K
M
Markus Graefen
H-index: 119 · Papers: 1.8K
O
Oliver Sartor
H-index: 95 · Papers: 1.3K
View more